BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 30543990)

  • 1. Rare missense TUBGCP5 gene variant in a patient with primary microcephaly.
    Maver A; Čuturilo G; Kovanda A; Miletić A; Peterlin B
    Eur J Med Genet; 2019 Dec; 62(12):103598. PubMed ID: 30543990
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The 15q11.2 BP1-BP2 Microdeletion (
    Rafi SK; Butler MG
    Int J Mol Sci; 2020 May; 21(9):. PubMed ID: 32384786
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prenatal diagnosis of a familial 15q11.2 (BP1-BP2) microdeletion encompassing TUBGCP5, CYFIP1, NIPA2 and NIPA1 in a fetus with ventriculomegaly, microcephaly and intrauterine growth restriction on prenatal ultrasound.
    Chen CP; Chang SY; Wang LK; Chang TY; Chern SR; Wu PS; Chen SW; Lai ST; Chuang TY; Yang CW; Town DD; Chen LF; Wang W
    Taiwan J Obstet Gynecol; 2018 Oct; 57(5):730-733. PubMed ID: 30342661
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Magnesium Supplement and the 15q11.2 BP1-BP2 Microdeletion (Burnside-Butler) Syndrome: A Potential Treatment?
    Butler MG
    Int J Mol Sci; 2019 Jun; 20(12):. PubMed ID: 31207912
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and genetic aspects of the 15q11.2 BP1-BP2 microdeletion disorder.
    Butler MG
    J Intellect Disabil Res; 2017 Jun; 61(6):568-579. PubMed ID: 28387067
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genomic, Clinical, and Behavioral Characterization of 15q11.2 BP1-BP2 Deletion (Burnside-Butler) Syndrome in Five Families.
    Baldwin I; Shafer RL; Hossain WA; Gunewardena S; Veatch OJ; Mosconi MW; Butler MG
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33562221
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 15q11.2 microdeletion (BP1-BP2) and developmental delay, behaviour issues, epilepsy and congenital heart disease: a series of 52 patients.
    Vanlerberghe C; Petit F; Malan V; Vincent-Delorme C; Bouquillon S; Boute O; Holder-Espinasse M; Delobel B; Duban B; Vallee L; Cuisset JM; Lemaitre MP; Vantyghem MC; Pigeyre M; Lanco-Dosen S; Plessis G; Gerard M; Decamp M; Mathieu M; Morin G; Jedraszak G; Bilan F; Gilbert-Dussardier B; Fauvert D; Roume J; Cormier-Daire V; Caumes R; Puechberty J; Genevieve D; Sarda P; Pinson L; Blanchet P; Lemeur N; Sheth F; Manouvrier-Hanu S; Andrieux J
    Eur J Med Genet; 2015 Mar; 58(3):140-7. PubMed ID: 25596525
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Familial transmission of recurrent 15q11.2 (BP1-BP2) microdeletion encompassing NIPA1, NIPA2, CYFIP1, and TUBGCP5 associated with phenotypic variability in developmental, speech, and motor delay.
    Chen CP; Lin SP; Lee CL; Chern SR; Wu PS; Chen YN; Chen SW; Wang W
    Taiwan J Obstet Gynecol; 2017 Feb; 56(1):93-97. PubMed ID: 28254235
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deciphering the RNA-binding protein interaction with the mRNAs encoded from human chromosome 15q11.2 BP1-BP2 microdeletion region.
    Biswal SR; Singh M; Dwibedy SLL; Kumari S; Muthuswamy S; Kumar A; Kumar S
    Funct Integr Genomics; 2023 May; 23(2):174. PubMed ID: 37219715
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intrauterine ultrasound phenotyping, molecular characteristics, and postnatal follow-up of fetuses with the 15q11.2 BP1-BP2 microdeletion syndrome: a single-center, retrospective clinical study.
    Cai M; Lv A; Zhao W; Xu L; Lin N; Huang H
    BMC Pregnancy Childbirth; 2024 Jan; 24(1):23. PubMed ID: 38172840
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nine patients with a microdeletion 15q11.2 between breakpoints 1 and 2 of the Prader-Willi critical region, possibly associated with behavioural disturbances.
    Doornbos M; Sikkema-Raddatz B; Ruijvenkamp CA; Dijkhuizen T; Bijlsma EK; Gijsbers AC; Hilhorst-Hofstee Y; Hordijk R; Verbruggen KT; Kerstjens-Frederikse WS; van Essen T; Kok K; van Silfhout AT; Breuning M; van Ravenswaaij-Arts CM
    Eur J Med Genet; 2009; 52(2-3):108-15. PubMed ID: 19328872
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of a novel familial deletion of four genes between BP1 and BP2 of the Prader-Willi/Angelman syndrome critical region by oligo-array CGH in a child with neurological disorder and speech impairment.
    Murthy SK; Nygren AO; El Shakankiry HM; Schouten JP; Al Khayat AI; Ridha A; Al Ali MT
    Cytogenet Genome Res; 2007; 116(1-2):135-40. PubMed ID: 17268193
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adverse Perinatal and Early Life Outcomes following 15q11.2 CNV Diagnosis.
    Chu FC; Shaw SW; Lee CH; Lo LM; Hsu JJ; Hung TH
    Genes (Basel); 2021 Sep; 12(10):. PubMed ID: 34680874
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment-resistant psychotic symptoms and the 15q11.2 BP1-BP2 (Burnside-Butler) deletion syndrome: case report and review of the literature.
    Farrell M; Lichtenstein M; Harner MK; Crowley JJ; Filmyer DM; Lázaro-Muñoz G; Dietterich TE; Bruno LM; Shaughnessy RA; Biondi TF; Burkholder S; Donmoyer J; Berg JS; Szatkiewicz J; Sullivan PF; Josiassen RC
    Transl Psychiatry; 2020 Jan; 10(1):42. PubMed ID: 32066678
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SLC1A4 mutations cause a novel disorder of intellectual disability, progressive microcephaly, spasticity and thin corpus callosum.
    Heimer G; Marek-Yagel D; Eyal E; Barel O; Oz Levi D; Hoffmann C; Ruzzo EK; Ganelin-Cohen E; Lancet D; Pras E; Rechavi G; Nissenkorn A; Anikster Y; Goldstein DB; Ben Zeev B
    Clin Genet; 2015 Oct; 88(4):327-35. PubMed ID: 26138499
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical features and magnesium levels: Novel insights in 15q11.2 BP1-BP2 copy number variants.
    Meossi C; Carrer A; Ciaccio C; Estienne M; Silipigni R; Sciacca FL; Pantaleoni C; D'Arrigo S; Milani D
    J Intellect Disabil Res; 2023 Jul; 67(7):679-689. PubMed ID: 37129092
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutations of KIF14 cause primary microcephaly by impairing cytokinesis.
    Moawia A; Shaheen R; Rasool S; Waseem SS; Ewida N; Budde B; Kawalia A; Motameny S; Khan K; Fatima A; Jameel M; Ullah F; Akram T; Ali Z; Abdullah U; Irshad S; Höhne W; Noegel AA; Al-Owain M; Hörtnagel K; Stöbe P; Baig SM; Nürnberg P; Alkuraya FS; Hahn A; Hussain MS
    Ann Neurol; 2017 Oct; 82(4):562-577. PubMed ID: 28892560
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel WDR62 mutation causes primary microcephaly in a large consanguineous Saudi family.
    Naseer MI; Rasool M; Sogaty S; Chaudhary RA; Mansour HM; Chaudhary AG; Abuzenadah AM; Al-Qahtani MH
    Ann Saudi Med; 2017; 37(2):148-153. PubMed ID: 28377545
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of Pathogenic Mutations in Primary Microcephaly- (MCPH-) Related Three Genes
    Khan NM; Masoud MS; Baig SM; Qasim M; Chang J
    Biomed Res Int; 2022; 2022():3769948. PubMed ID: 35281599
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel compound heterozygous mutations in GPT2 linked to microcephaly, and intellectual developmental disability with or without spastic paraplegia.
    Kaymakcalan H; Yarman Y; Goc N; Toy F; Meral C; Ercan-Sencicek AG; Gunel M
    Am J Med Genet A; 2018 Feb; 176(2):421-425. PubMed ID: 29226631
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.